Cargando…
Does colchicine reduce mortality in patients with COVID-19 clinical syndrome? An umbrella review of published meta-analyses
BACKGROUND: Despite significant improvements in both treatment and prevention strategies, as well as multiple commissioned reviews, there remains uncertainty regarding the survival benefit of repurposed drugs such as colchicine in patients with Coronavirus Disease 2019 (COVID-19) clinical syndrome....
Autores principales: | Danjuma, Mohammed I., Sayed, Rana, Aboughalia, Maryam, Hassona, Aseel, Elsayed, Basant Selim, Elshafei, Mohamed, Elzouki, Abdelnaser |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10520783/ https://www.ncbi.nlm.nih.gov/pubmed/37767472 http://dx.doi.org/10.1016/j.heliyon.2023.e20155 |
Ejemplares similares
-
Colchicine and mortality outcomes in patients with coronavirus disease (COVID-19)
por: Danjuma, Mohammed I., et al.
Publicado: (2023) -
Colchicine use might be associated with lower mortality in COVID‐19 patients: A meta‐analysis
por: Elshafei, Mohamed Nabil, et al.
Publicado: (2021) -
The efficacy of colchicine in the management of coronavirus disease 2019: A protocol for systematic review and meta-analysis
por: Elshafei, Mohamed Nabil, et al.
Publicado: (2020) -
Risk factors for eating disorders: an umbrella review of published meta-analyses
por: Solmi, Marco, et al.
Publicado: (2020) -
Prevalence and global trends of polypharmacy among people living with HIV: a systematic review and meta-analysis
por: Danjuma, Mohammed I., et al.
Publicado: (2022)